The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice

被引：0
|
作者：
Frank Michael Klenke
Martha-Maria Gebhard
Volker Ewerbeck
Amir Abdollahi
Peter E Huber
Axel Sckell
机构：
[1] University of Bern,Department of Orthopedic Surgery, Inselspital
[2] University of Heidelberg,Department of Experimental Surgery
[3] INF 365,Department of Orthopaedic Surgery
[4] University of Heidelberg,Department of Trauma and Reconstructive Surgery
[5] German Cancer Research Center,undefined
[6] INF 280,undefined
[7] Charité – Campus Benjamin Franklin,undefined
来源：
BMC Cancer | / 6卷
关键词：
Vascular Endothelial Growth Factor; Bone Metastasis; Celecoxib; Tumor Implantation; Intravital Microscopy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The selective Cox-2 inhibitor Celecoxib suppresses angiogenesis and growth of secondary bone tumors: An intravital microscopy study in mice
    Klenke, FM
    Gebhard, MM
    Ewerbeck, V
    Abdollahi, A
    Huber, PE
    Sckell, A
    BMC CANCER, 2006, 6 (1)
  • [2] Clinical pharmacology of celecoxib, a COX-2 selective inhibitor
    Antoniou, Katerina
    Malamas, Michael
    Drosos, Alexandros A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (11) : 1719 - 1732
  • [3] Discovery of the COX-2 selective inhibitor celecoxib.
    Talley, JJ
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 219 : U56 - U56
  • [4] In vivo treatment with celecoxib, an inhibitor of COX-2, suppresses serum levels of bone resorption but not bone formation markers in ovariectomized mice
    Kasukawa, Y
    Miyakoshi, N
    Srivastava, A
    Nozaka, K
    Maekawa, S
    Baylink, DJ
    Mohan, S
    Itoi, E
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S282 - S282
  • [5] Caution in using Celecoxib: Induction of VEGF and Angiogenesis by This COX-2 Inhibitor
    Shu, H.
    Gao, H.
    Xu, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S626 - S626
  • [6] The selective COX-2 inhibitor celecoxib modulates sphingolipid synthesis
    Schiffmann, Susanne
    Sandner, Jessica
    Schmidt, Ronald
    Birod, Kerstin
    Wobst, Ivonne
    Schmidt, Helmut
    Angioni, Carlo
    Geisslinger, Gerd
    Groesch, Sabine
    JOURNAL OF LIPID RESEARCH, 2009, 50 (01) : 32 - 40
  • [7] COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer
    Yoshinaka, Ryoji
    Shibata, Masa-Aki
    Morimoto, Junji
    Tanigawa, Nobuhiko
    Otsuki, Yoshinori
    ANTICANCER RESEARCH, 2006, 26 (6B) : 4245 - 4254
  • [8] DFU, a selective COX-2 inhibitor, suppresses MCF-7 xenograft tumor growth in mice
    Matsumoto, G
    Rahman, MA
    Muta, M
    Nakamura, T
    Bando, H
    Saji, S
    Tsuruta, K
    Okamoto, A
    Toi, M
    ONCOLOGY REPORTS, 2004, 12 (02) : 281 - 285
  • [9] Impact of the COX-2 selective inhibitor celecoxib on initiation and progression of atherosclerosis
    Metzner, J
    Manderscheid, C
    Popp, L
    Coste, O
    Geisslinger, G
    Niederberger, E
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 372 : 23 - 23
  • [10] Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib, leading to massive tumour necrosis and inhibition of angiogenesis
    Kang, Khong Bee
    Wang, Ting Ting
    Woon, Chow Thai
    Cheah, Sor Tin
    Moore, Xiao Lei
    Zhu, Congju
    Wong, Meng Cheong
    CANCER RESEARCH, 2006, 66 (08)
12345